Literature DB >> 32130795

Delineation of musculocontractural Ehlers-Danlos Syndrome caused by dermatan sulfate epimerase deficiency.

Charlotte K Lautrup1, Keng W Teik2, Ai Unzaki3,4, Shuji Mizumoto5, Delfien Syx6, Heng H Sin7, Irene K Nielsen1, Sara Markholt8, Shuhei Yamada5, Fransiska Malfait6, Naomichi Matsumoto9, Noriko Miyake9, Tomoki Kosho3,10.   

Abstract

BACKGROUND: Musculocontractural Ehlers-Danlos Syndrome (mcEDS) is a rare connective tissue disorder caused by biallelic loss-of-function variants in CHST14 (mcEDS-CHST14) or DSE (mcEDS-DSE), both of which result in defective dermatan sulfate biosynthesis. Forty-one patients with mcEDS-CHST14 and three patients with mcEDS-DSE have been described in the literature.
METHODS: Clinical, molecular, and glycobiological findings in three additional patients with mcEDS-DSE were investigated.
RESULTS: Three patients from two families shared craniofacial characteristics (hypertelorism, blue sclera, midfacial hypoplasia), skeletal features (pectus and spinal deformities, characteristic finger shapes, progressive talipes deformities), skin features (fine or acrogeria-like palmar creases), and ocular refractive errors. Homozygous pathogenic variants in DSE were found: c.960T>A/p.Tyr320* in patient 1 and c.996dupT/p.Val333Cysfs*4 in patients 2 and 3. No dermatan sulfate was detected in the urine sample from patient 1, suggesting a complete depletion of DS.
CONCLUSION: McEDS-DSE is a congenital multisystem disorder with progressive symptoms involving craniofacial, skeletal, cutaneous, and cardiovascular systems, similar to the symptoms of mcEDS-CHST14. However, the burden of symptoms seems lower in patients with mcEDS-DSE.
© 2020 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.

Entities:  

Keywords:  clinical features; delineation; dermatan sulfate; musculocontractural EDS-DSE

Mesh:

Substances:

Year:  2020        PMID: 32130795      PMCID: PMC7216804          DOI: 10.1002/mgg3.1197

Source DB:  PubMed          Journal:  Mol Genet Genomic Med        ISSN: 2324-9269            Impact factor:   2.183


INTRODUCTION

Musculocontractural Ehlers–Danlos Syndrome (mcEDS) is a rare connective tissue disorder, caused by biallelic loss‐of‐function variants in CHST14 (mcEDSCHST14) (MIM#601776) or in DSE (mcEDSDSE) (MIM#615539), both of which result in defective dermatan sulfate (DS) biosynthesis (Brady, Demirdas, & Fournel‐Gigleux, 2017; Malfait, Francomano, & Byers, 2017). Hallmarks of mcEDS include altered craniofacial features, multiple congenital contractures (e.g., adducted thumbs, talipes equinovarus), characteristic fine palmar creases, peculiar finger shapes, progressive spinal and foot deformities, large subcutaneous hematomas, and ophthalmological and urogenital involvement (Brady et al., 2017). Only five patients with mcEDSDSE have been described in the literature (Müller, Mizumoto, & Suresh, 2013; Schirwani et al., 2019; Syx, Van Damme, & Symoens, 2015) in contrast to 41 patients with mcEDSCHST14 (Brady et al., 2017; Kono, Hasegawa‐Murakami, & Sugiura, 2016; Sandal & Kaur, 2018). Here, we report detailed clinical, molecular, and glycobiological findings in three additional patients with mcEDSDSE.

CLINICAL REPORT

Patient 1, a 19‐year‐old man and average high school student, was born of consanguineous Turkish parents. Pregnancy was complicated by premature rupture of membranes and he was delivered by emergency cesarean section at gestational week 29. At birth, he exhibited cyanosis and bradycardia with Apgar scores of 7 at 1 min and 10 at 5 min. His birth weight was 1,215 g (−1 standard deviation [SD]), length was 35 cm (−3 SDs), and occipitofrontal circumference (OFC) was 26.7 cm (−0.5 SD). In infancy to early childhood, he exhibited large anterior fontanel, brachycephaly, low hairline, wide neck, hypertelorism, blue sclera, short nose with hypoplastic columella, long philtrum, and thin upper lip vermilion. He had bilateral adducted thumbs, arachnodactyly, and rocker bottom feet, but did not exhibit talipes equinovarus. He had umbilical hernia, diastasis recti, bilateral hydronephrosis, and cryptorchidism. He experienced recurrent constipation, which was treated with laxatives. Echocardiography revealed an atrial septal defect and patent ductus arteriosus. He exhibited delayed motor development and mild hypotonia; he sat without support at age 8 months and walked unassisted at 18 months. He underwent surgeries for strabismus and cryptorchidism at 3 and 5 years of age, respectively. At 8 years of age, brain magnetic resonance imaging showed cortical heterotopia. He was diagnosed with myopia and strabismus, and later diagnosed with unilateral 40 dB high‐frequency sensorineural hearing loss. During his school years, he experienced repeated shoulder luxation and large subcutaneous hematomas at various locations (each antebrachium and the gluteal region) after minor traumas and without the evidence of coagulation defects. He had mild scoliosis and joint hypermobility, and underwent surgery for pes cavus at 11 years of age. His skin was hyperextensible with delayed wound healing. At 15 years of age, he had a self‐limiting hemoptysis with no evidence of tuberculosis. At 18 years of age, his height was 178 cm (−0.2 SD), weight was 77 kg (+0.5 SD), and OFC was 58 cm (+2 SDs). He had downslanting palpebral fissures, grey sclera, but no hypertelorism. His ears were not rotated or low‐set; however, his right ear showed underfolded helix, lower insertion of the lobule than on the left side, and pits on the posterior conchae. He had dental crowding, and his skin was hyperextensible, with fine palmar (Figure 1b) and solar creases, and broadened surgical scars on the right foot (Figure 1d). His fingers were long and slender with joint laxity and a swan‐neck deformity, as well as the radial deviation of the bilateral second to fourth fingers (Figure 1a). He had bilateral pes cavus (Figure 1e), mild pectus excavatum (Figure 1c), and lumbar scoliosis. He had no echocardiographic abnormalities, but was diagnosed with high blood pressure and treated with an angiotensin‐converting enzyme inhibitor.
Figure 1

Clinical photographs of patient 1 at 18 years of age (a−e), patient 2 at 12.5 years of age (f−h), and patient 3 at 21 years of age (i−m)

Clinical photographs of patient 1 at 18 years of age (a−e), patient 2 at 12.5 years of age (f−h), and patient 3 at 21 years of age (i−m) Patient 2, a 14‐year‐old girl and average student, was born of consanguineous Indian parents. After an uncomplicated pregnancy, she had been delivered vaginally at term with a birth weight of 2.5 kg; she had normal developmental milestones. She experienced intermittent joint pain and swelling after exercise (left knee and right ankle) and exhibited scoliosis at 11 years of age. She had astigmatism, but normal hearing. At 12.5 years of age, her height was 141 cm, weight was 27.9 kg, and OFC was 48 cm (all below the third centile). She had hypertelorism, blue sclera, and a broad tall nasal bridge; she had no skin hyperextensibility or apparent scars. Her fingers and toes were long with mild finger webbing (Figure 1f,h), and crisscrossing palmar and solar creases (Figure 1g). Joint laxity was limited to the dorsal subluxation of the metacarpophalangeal joints, especially the thumbs. Her chest was asymmetric with pectus carinatum and she had thoracic kyphoscoliosis. Her bone mineral density, measured by dual‐energy X‐ray absorptiometry, was reduced to 0.659 g/cm2 at the lumbar spine (normal range for 20‐year‐old women, 0.8−1.2 g/cm2), and 0.513 g/cm2 at the femoral neck (normal range for 20‐year‐old women, 0.6−1.0 g/cm2). She had no echocardiographic abnormalities or muscle weakness. Patient 3, a 22‐year‐old man and the older brother of patient 2, was born at term after an uncomplicated pregnancy, with a birth weight of 2.9 kg. He had bilateral talipes equinovarus, which was treated with serial casting and surgical correction at 1 year of age. His early psychomotor development was normal. He experienced right arm fracture after a fall at 4 years of age and right fifth finger fracture at 7 years of age. He developed a large subcutaneous hematoma in his left calf twice, both requiring surgical evacuation. He also had intermittent bruises over his shins. He exhibited scoliosis at 14 years of age, which progressed and required surgical correction at 20 years of age. He had myopia, but normal hearing. He attended a normal school, but did not perform well. At 21 years of age, his height was 151 cm and weight was 40 kg (both below the third centile). He had small simple ears, mild hypertelorism, blue sclera, a broad tall nasal bridge (Figure 1i), and retained primary teeth. Atrophic surgical scars, finger webbing, and abnormal palmar (Figure 1j,k) and solar creases were present; skin hyperextensibility was absent. He had an asymmetric chest (Figure 1i), long fingers and toes (Figure 1l,m), hallux valgus, and plantar subluxation of the metatarsophalangeal joint of the halluces, as well as prominent calcaneus (Figure 1m). He developed multiple joint contractures resulting in reduced ankle dorsiflexion, hip flexion, elbow extension, and wrist dorsiflexion.

MOLECULAR INVESTIGATION

Sanger sequencing of CHST14 and DSE was performed for patient 1 based on clinical suspicion of mcEDS. No pathogenic variants were detected in CHST14; a homozygous nonsense variant was identified in DSE (NM_013352.4, c.960T>A, p.(Tyr320*)) (Figure 2a). For patient 2, whole exome sequencing was performed (Data S1; Miyake, Tsurusaki, & Koshimizu, 2016) and a homozygous frameshift variant was identified in DSE (NM_013352.4, c.996dupT, p.(Val333Cysfs*4)); patient 3 exhibited homozygosity for this variant, whereas their parents exhibited heterozygosity (Figure 2a). None of the identified DSE variants were registered in ExAC, Exome Variant Server, or Human Genetic Variant Database.
Figure 2

Molecular investigation. (a) Pedigree information and intrafamilial segregation of detected variants in DSE. (b) cDNA structure of DSE and pathogenic variants (mcEDS‐DSE). Untranslated regions (UTRs) are shown as orange bars. The first base and each position of exon‐exon junctions in open reading frames (ORFs) are shown in light blue. Pathogenic variants reported in this study are shown in red characters. ex: exon

Molecular investigation. (a) Pedigree information and intrafamilial segregation of detected variants in DSE. (b) cDNA structure of DSE and pathogenic variants (mcEDSDSE). Untranslated regions (UTRs) are shown as orange bars. The first base and each position of exon‐exon junctions in open reading frames (ORFs) are shown in light blue. Pathogenic variants reported in this study are shown in red characters. ex: exon

GLYCOBIOLOGICAL ANALYSIS

Disaccharide compositions of DS and chondroitin sulfate (CS) chains in urine samples from patient 1 and an age‐matched healthy man were analyzed as described previously (Data S2; Mizumoto, Kosho, & Hatamochi, 2017). DS disaccharide was not detected in the urine of patient 1, whereas it was present in the urine of the age‐matched healthy man (Figure S1; Table S1A). In contrast, the amount of CS disaccharides in the urine was similar between patient 1 and the age‐matched healthy man (Figure S1; Table S1B).

DISCUSSION

We presented three patients with mcEDSDSE from two new families. Clinical and molecular features of the five previously reported patients (Müller et al., 2013; Schirwani et al., 2019; Syx et al., 2015), including additional information of the sisters reported by Syx et al. (2015) and the three patients in this series are reviewed in Table 1. Truncating variants in DSE were identified in the three current patients, whereas previously detected variants were missense in three families and a frameshift variant in one family. Significant reduction or loss of epimerase activity and a marked reduction in DS disaccharides were demonstrated in the patient with p.(Ser268Leu) (Müller et al., 2013). A minor fraction of DS was detected as the glycosaminoglycan component of decorin in the patient with p.(Arg267Gly) (Syx et al., 2015). The preservation of DS moieties in mcEDSDSE, in contrast to the complete loss of DS in mcEDSCHST14 (Dündar, Müller, & Zhang, 2009; Miyake, Kosho, & Mizumoto, 2010), suggested the residual activity of mutant DSE or partially compensating activity of dermatan sulfate epimerase‐like protein (encoded by DSEL) (Syx et al., 2015). The measurement of the disaccharide compositions of DS and CS chains in a urine sample is a recently established non‐invasive method to screen for mcEDSCHST14 through the assessment of DS biosynthesis (Mizumoto et al., 2017). The lack of DS in the urine sample from patient 1 in this study suggests that this test may also be useful for screening of mcEDSDSE.
Table 1

Clinical and molecular features of patients with mcEDS‐DSE

Patient12345678Total (n = 8)mcEDS‐CHST14 (n = 41)
Family123456  
PublicationMüller et al. (2013)Syx et al. (2015)Schirwani et al. (2019)This study  
 Patient 1Patient 2Patient 1Patient 2Patient 3  
Mutation (cDNA)c.803C>T/homoc.799A>G/homoc.1150_1157del/homoc.1763A>G/homoc.960T>A/homoc.996dupT/homo  
Amino acid change (amino acid)p.Ser268Leup.Arg267Glyp.Pro384Trpfs*9p.His588Argp.Tyr320*p.Val333Cysfs*4  
Age at the publication (years)24839332191422  
SexMFFMMMFMM 5, F 3M 22, F 19
OriginIndianSpanishPortuguesePakistaniTurkishIndian  
Craniofacial
Large fontanel with delayed closure (early childhood)YesNRNRNRYesYesNRNR3/3 (100%)23
Small mouth/micro‐retrognathia (infancy)NRYesYesYesNRNRNRNR3/3 (100%) 
Slender face/protruding jaw (from adolescence)NRNRNRYes a NRNoNoYes2/4 (50%)11
Facial asymmetricity (from adolescence)NRNRNRNo a NRYesNoNo1/4 (25%)10
HypertelorismYesYesYesNRNRYesYesYes6/6 (100%)35
Downslanting palpebral fissuresYesYesYesYesYesYesNoYes7/8 (88%)34
Short palpebral fissuresNRYesYesNo a YesYesNoNo4/7 (57%) 
Blue scleraYesYesYesNRNRYesYesYes6/6 (100%)25
Midfacial hypoplasiaNRYesYesNo a NRYesYesYes5/6 (83%) 
Short nose with hypoplastic columellaNRYesYesNo a No a NoNoNo2/7 (29%)16
Ear deformity (e.g. low‐set, posterior rotation, prominent)YesYesYesYesYesYesNoYes7/8 (88%)33
Palatal abnormalities (e.g. high, cleft)YesNRNRYesNoNoYesNR3/5 (60%)25
Long philtrum and/or thin upper lip vermilionNRYes (thin upper lip vermilion)Yes (both)No a Yes (thin upper lip vermilion) a NoNoNo3/7 (43%)24
Crowded teethYesNRNRYesNRYesNRNR3/3 (100%) 
Brachycephaly/flat occiputYesNRNRNo a YesYesNoNo3/6 (50%) 
Others Hypotonic face with wrinkled and saggy eyelids, cheeks, and neck Prominent forehead      
Skeletal
Congenital multiple contractures a YesYesYesYesYesYesNoYes7/8 (88%)41
Adducted thumbsYes (bil)NoNoYes (bil)Yes (bil)Yes (bil)NoNo4/8 (50%)33
Talipes equinovarusYes (bil)Yes (bil)Yes (bil)Yes (bil)Yes (bil)NoNoYes (bil)6/8 (75%)41
Recurrent/chronic joint dislocationsNRNoNRNoNoYes (shoulder)NoNo1/6 (17%)20
Pectus deformiltiesNRNRNRNRNoYes (mild excavatum)Yes (excavatum, asymmetric)Yes (excavatum, asymmetric)3/4 (75%)18
Spinal deformitiesNRNoYes (mild to moderate scoliosis)NoNoYes (mild lumbar scoliosis)Yes (scoliosis, thoracic kyphoscoliosis)Yes (scoliosis)4/7 (57%)22
Finger shape characteristicsYes (long, tapering)Yes (long, slender, tapering)Yes (long, slender, tapering)Yes (cylingdrical)Yes (long, slender)Yes (long, slender)Yes (long, slender)Yes (long, slender)8/8 (100%)35
Progressive foot deformitiesNRYes (short, broad feet with short toes)NRYes (wide feet with clawed toes)YesYes (cavus)Yes (uni. planus)Yes (hallux valgus, planus, cavus)6/6 (100%)26
Marfanoid habitus/slender buildNRNRNRNoNRNoYesYes2/4 (50%)13
Joint hypermobilityYesYes b Yes b NoNRYesNoNo4/7 (57%) 
OsteoporosisNRNRNRNRNRNRYesNR1/1 (100%) 
Others Joint pain Chronic pain, brachydactyly, Madelung deformityTorticollis Joint painFractures  
Skin
HyperextensibilityNRYesYesNo c NoYesNoNo3/7 (43%)24
BruisabilityNRYesYesNRYesNoNoYes4/6 (67%)21
FragilityNRYesYesNoNoNoNoNo2/7 (29%)21
Atrophic scarsYesNRNRNRNoNoNoYes2/5 (40%) 
Hyperalgesia to pressureNRNRNRNRNRNRNRNR0/0 (0%)8
Fine or acrogeria‐like palmar creasesYesYesYesYesNoYesYesYes7/8 (88%)28
Recurrent subcutaneous infectionsNRNRNRNRNRNoNoNo0/3 (0%)8
Fistula formationNRNRNRNRNRNoNoNo0/3 (0%) 
Delayed wound healingYesNRNRNRNRYesNoNo2/4 (50%) 
Umbilical herniaNRNRNRNRNRYesNoNo1/3 (33%) 
Others Transparent, thinTransparent, thinPiezogenic pedal papules      
Cardiovascular
Congenital heart defectsYes (PFO)NRNoNoYes (ASD)Yes (ASD, PDA)NoNR3/6 (50%)6
Valve abnormalitiesNoYes (MVP, myxomatous valve with ruptureed chordae, severe MR)NoNoNRNoNoNR1/6 (17%)7
Enlargement of ascending aortaNoNoNoNoNRNoNoNR0/6 (0%)2
Large subcutaneous hematomaNRYesYesNRNoYes (elbow, arm, forehead, knee, gluteal region)NRYes (calf)4/5 (80%)20
Respiratory
Pneumothorax/HemopneumothoraxNRNRNRNoNoNoNoNo0/5 (0%)3
Gastrointestinal
ConstipationNRNRNRNoNoYesNoNo1/5 (20%)9
Diverticula (e.g. perforation, infection)NRNRNRNoNoNoNoNo0/5 (0%)4
Others  Eventration after gallbladder surgery       
Urological
Nephrolithiasis or cystolithiasisNRNRNRNRNRNoNRNR0/1 (0%)7
HydronephrosisNRNRNRNoNRYes (bil)NRNR1/2 (50%)10
Bladder dysfunctionNRYes (prolapse after two deliveries)NRNRNRNoNRNR1/2 (50%)2
Recurrent urinary tract infectionNRNRNRNRNRNoNRNR0/1 (0%)3
Inguinal herniaYes (lt)NRYesYes (bil)NRYes (lt)NoNo4/6 (67%)2
Cryptorchidism in maleNR  YesNoYes (bil) No2/4 (50%)17
Ophthalmological
StrabismusNRNoNoNoYesYes (esotropia)NoNo2/7 (29%)14
Glaucoma or elevated intraocular pressureNRNoNoNoNoNoNoNo0/7 (0%)8
Refractive errorNRNoNoYes (my)NoYes (my)Yes (as)Yes (my)4/7 (57%)16 (hy 4, my 12, as 5)
Retinal detachmentNRNoNoNRNRNoNoNo0/5 (0%)6
Otological
Hearing impairmentNRNRNRNRNRYes (mild, uni, SNHL for high‐pitched sound)NoNo1/3 (33%)10
Sexual development‐related
HypogonadismNRNRNRNRNRNoNRNo0/2 (0%) 
Others Uterine prolapse after two deliveries        
Central nervous system
Ventricular abnormalities (enlargement, asymmetry)NoNRNRNRNoNoNRNR0/3 (0%)8
Hypoplasia of septum pellucidumNoNRNRNRNoNoNRNR0/3 (0%) 
Dandy‐Walker variantNoNRNRNRNoNoNRNR0/3 (0%) 
Muscular system
HypotoniaNRYesYesNRNRYesNRNR3/3 (100%)14
Muscle weaknessYesYesNRNRNRYesNoNo3/5 (60%) 
Development
Motor developmental delayYesNRNRNRYesYesNoNR3/4 (75%)23
Intellectual disabilitiesNoNRNRNoNRNoNoYes1/5 (20%)4

Abbreviations: as, astigmatism; ASD, atrial septal defect; bil, bilateral; F, female; hy, hyperopia; lt, left; M, male; MR, mitral valve regurgitation; MVP, mitral valve prolapse; my, myopia; No, absent; NR, not recorded; PDA, patent ductus arteriosus; PFO, persistent foramen ovale; SNHL, sensorineural hearing loss; uni, unilateral; Yes, present.

Judged from images in the relevant report.

In younger ages but not in adulthood.

Only at the elbows.

Clinical and molecular features of patients with mcEDSDSE Abbreviations: as, astigmatism; ASD, atrial septal defect; bil, bilateral; F, female; hy, hyperopia; lt, left; M, male; MR, mitral valve regurgitation; MVP, mitral valve prolapse; my, myopia; No, absent; NR, not recorded; PDA, patent ductus arteriosus; PFO, persistent foramen ovale; SNHL, sensorineural hearing loss; uni, unilateral; Yes, present. Judged from images in the relevant report. In younger ages but not in adulthood. Only at the elbows. Frequent (affecting at least three patients) craniofacial and skeletal features in mcEDSDSE are shown in Table 1. Two reported patients (Schirwani et al., 2019; Syx et al., 2015) and patient 2 in the present report had joint pain. Frequent skin, vascular, ocular, nervous, and muscle features are also shown in Table 1. Even though the number of patients with mcEDSDSE is small and an accurate frequency of each feature in patients with mcEDSCHST14 is unavailable, the general patterns of symptoms seem to be similar between the two subtypes. However, several patients with mcEDSCHST14 had life‐threatening complications (e.g., infectious endocarditis, Kono et al., 2016; Kosho, Miyake, & Hatamochi, 2010, fulminant gastric ulcer, Kosho et al., 2010; diverticular perforation, Kosho et al., 2010; Mochida, Amano, & Miyake, 2016), and five patients died (Dündar, Kurtoglu, & Elmas, 2001; Janecke, Li, & Boehm, 2016). No such serious complication has yet been observed in patients with mcEDSDSE. Syx et al. (2015) hypothesized that the residual availability of some DS structures, including iduronic acid‐containing disaccharide units, might contribute to an attenuated phenotype. In conclusion, mcEDSDSE constitutes a multisystem disorder with congenital and progressive features, as well as the depletion of DS, similar to mcEDSCHST14. However, symptoms tend to be milder in patients with mcEDSDSE.

CONFLICT OF INTEREST

The authors declare no conflict of interest. FigS1 Click here for additional data file. TableS1 Click here for additional data file. TableS2 Click here for additional data file. DataS1 Click here for additional data file. DataS2 Click here for additional data file.
  16 in total

1.  A case with adducted thumb and club foot syndrome.

Authors:  M Dundar; S Kurtoglu; B Elmas; F Demiryilmaz; Z Candemir; Y Ozkul; A C Durak
Journal:  Clin Dysmorphol       Date:  2001-10       Impact factor: 0.816

2.  Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndrome.

Authors:  Noriko Miyake; Tomoki Kosho; Shuji Mizumoto; Tatsuya Furuichi; Atsushi Hatamochi; Yoji Nagashima; Eiichi Arai; Kazuo Takahashi; Rie Kawamura; Keiko Wakui; Jun Takahashi; Hiroyuki Kato; Hiroshi Yasui; Tadao Ishida; Hirofumi Ohashi; Gen Nishimura; Masaaki Shiina; Hirotomo Saitsu; Yoshinori Tsurusaki; Hiroshi Doi; Yoshimitsu Fukushima; Shiro Ikegawa; Shuhei Yamada; Kazuyuki Sugahara; Naomichi Matsumoto
Journal:  Hum Mutat       Date:  2010-08       Impact factor: 4.878

3.  The phenotype of the musculocontractural type of Ehlers-Danlos syndrome due to CHST14 mutations.

Authors:  Andreas R Janecke; Ben Li; Manfred Boehm; Birgit Krabichler; Marianne Rohrbach; Thomas Müller; Irene Fuchs; Gretchen Golas; Yasuhiro Katagiri; Shira G Ziegler; William A Gahl; Yael Wilnai; Nicoletta Zoppi; Herbert M Geller; Cecilia Giunta; Anne Slavotinek; Beat Steinmann
Journal:  Am J Med Genet A       Date:  2015-09-16       Impact factor: 2.802

4.  Dermatan 4-O-sulfotransferase 1-deficient Ehlers-Danlos syndrome complicated by a large subcutaneous hematoma on the back.

Authors:  Kosuke Mochida; Masahiro Amano; Noriko Miyake; Naomichi Matsumoto; Atsushi Hatamochi; Tomoki Kosho
Journal:  J Dermatol       Date:  2016-02-12       Impact factor: 4.005

Review 5.  The Ehlers-Danlos syndromes, rare types.

Authors:  Angela F Brady; Serwet Demirdas; Sylvie Fournel-Gigleux; Neeti Ghali; Cecilia Giunta; Ines Kapferer-Seebacher; Tomoki Kosho; Roberto Mendoza-Londono; Michael F Pope; Marianne Rohrbach; Tim Van Damme; Anthony Vandersteen; Caroline van Mourik; Nicol Voermans; Johannes Zschocke; Fransiska Malfait
Journal:  Am J Med Genet C Semin Med Genet       Date:  2017-03       Impact factor: 3.908

Review 6.  Genetic heterogeneity and clinical variability in musculocontractural Ehlers-Danlos syndrome caused by impaired dermatan sulfate biosynthesis.

Authors:  Delfien Syx; Tim Van Damme; Sofie Symoens; Merel C Maiburg; Ingrid van de Laar; Jenny Morton; Mohnish Suri; Miguel Del Campo; Ingrid Hausser; Trinh Hermanns-Lê; Anne De Paepe; Fransiska Malfait
Journal:  Hum Mutat       Date:  2015-04-06       Impact factor: 4.878

7.  Loss of dermatan-4-sulfotransferase 1 function results in adducted thumb-clubfoot syndrome.

Authors:  Munis Dündar; Thomas Müller; Qi Zhang; Jing Pan; Beat Steinmann; Julia Vodopiutz; Robert Gruber; Tohru Sonoda; Birgit Krabichler; Gerd Utermann; Jacques U Baenziger; Lijuan Zhang; Andreas R Janecke
Journal:  Am J Hum Genet       Date:  2009-12       Impact factor: 11.025

8.  Loss of dermatan sulfate epimerase (DSE) function results in musculocontractural Ehlers-Danlos syndrome.

Authors:  Thomas Müller; Shuji Mizumoto; Indrajit Suresh; Yoshie Komatsu; Julia Vodopiutz; Munis Dundar; Volker Straub; Arno Lingenhel; Andreas Melmer; Silvia Lechner; Johannes Zschocke; Kazuyuki Sugahara; Andreas R Janecke
Journal:  Hum Mol Genet       Date:  2013-05-23       Impact factor: 6.150

9.  Novel mutation in the CHST14 gene causing musculocontractural type of Ehlers-Danlos syndrome.

Authors:  Sapna Sandal; Anupriya Kaur; Inusha Panigrahi
Journal:  BMJ Case Rep       Date:  2018-09-23

10.  Delineation of musculocontractural Ehlers-Danlos Syndrome caused by dermatan sulfate epimerase deficiency.

Authors:  Charlotte K Lautrup; Keng W Teik; Ai Unzaki; Shuji Mizumoto; Delfien Syx; Heng H Sin; Irene K Nielsen; Sara Markholt; Shuhei Yamada; Fransiska Malfait; Naomichi Matsumoto; Noriko Miyake; Tomoki Kosho
Journal:  Mol Genet Genomic Med       Date:  2020-03-04       Impact factor: 2.183

View more
  7 in total

Review 1.  The Specific Role of Dermatan Sulfate as an Instructive Glycosaminoglycan in Tissue Development.

Authors:  Shuji Mizumoto; Shuhei Yamada
Journal:  Int J Mol Sci       Date:  2022-07-05       Impact factor: 6.208

2.  Delineation of musculocontractural Ehlers-Danlos Syndrome caused by dermatan sulfate epimerase deficiency.

Authors:  Charlotte K Lautrup; Keng W Teik; Ai Unzaki; Shuji Mizumoto; Delfien Syx; Heng H Sin; Irene K Nielsen; Sara Markholt; Shuhei Yamada; Fransiska Malfait; Naomichi Matsumoto; Noriko Miyake; Tomoki Kosho
Journal:  Mol Genet Genomic Med       Date:  2020-03-04       Impact factor: 2.183

3.  The structure of human dermatan sulfate epimerase 1 emphasizes the importance of C5-epimerization of glucuronic acid in higher organisms.

Authors:  Mahmudul Hasan; Hamed Khakzad; Lotta Happonen; Anders Sundin; Johan Unge; Uwe Mueller; Johan Malmström; Gunilla Westergren-Thorsson; Lars Malmström; Ulf Ellervik; Anders Malmström; Emil Tykesson
Journal:  Chem Sci       Date:  2020-12-08       Impact factor: 9.825

Review 4.  Animal Models of Ehlers-Danlos Syndromes: Phenotype, Pathogenesis, and Translational Potential.

Authors:  Robin Vroman; Anne-Marie Malfait; Rachel E Miller; Fransiska Malfait; Delfien Syx
Journal:  Front Genet       Date:  2021-10-12       Impact factor: 4.599

Review 5.  The Ehlers-Danlos Syndromes against the Backdrop of Inborn Errors of Metabolism.

Authors:  Tim Van Damme; Marlies Colman; Delfien Syx; Fransiska Malfait
Journal:  Genes (Basel)       Date:  2022-01-29       Impact factor: 4.096

6.  Clinical and molecular features of 66 patients with musculocontractural Ehlers-Danlos syndrome caused by pathogenic variants in CHST14 (mcEDS-CHST14).

Authors:  Mari Minatogawa; Ai Unzaki; Hiroko Morisaki; Delfien Syx; Tohru Sonoda; Andreas R Janecke; Anne Slavotinek; Nicol C Voermans; Yves Lacassie; Roberto Mendoza-Londono; Klaas J Wierenga; Parul Jayakar; William A Gahl; Cynthia J Tifft; Luis E Figuera; Yvonne Hilhorst-Hofstee; Alessandra Maugeri; Ken Ishikawa; Tomoko Kobayashi; Yoko Aoki; Toshihiro Ohura; Hiroshi Kawame; Michihiro Kono; Kosuke Mochida; Chiho Tokorodani; Kiyoshi Kikkawa; Takayuki Morisaki; Tetsuyuki Kobayashi; Takaya Nakane; Akiharu Kubo; Judith D Ranells; Ohsuke Migita; Glenda Sobey; Anupriya Kaur; Masumi Ishikawa; Tomomi Yamaguchi; Naomichi Matsumoto; Fransiska Malfait; Noriko Miyake; Tomoki Kosho
Journal:  J Med Genet       Date:  2021-11-23       Impact factor: 5.941

Review 7.  Chondrodysplasias With Multiple Dislocations Caused by Defects in Glycosaminoglycan Synthesis.

Authors:  Johanne Dubail; Valérie Cormier-Daire
Journal:  Front Genet       Date:  2021-06-16       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.